KARMA ONCOLOGY LIMITEDActive

Company number SC422204Private limited companyIncorporated 2012

Key figures

£517,851-30.4%
Net assets 2024/25
+4.9%
Average annual growth 2020/21–2024/25
0200 k400 k600 k800 k2020/212021/222022/232023/242024/25

Like most small UK companies, KARMA ONCOLOGY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand312,983772,205710,683776,144476,365
Total assets431,965855,570802,007776,838517,617
Total liabilities11,006399,27591,17636,2025,107
Net assets / total equity428,116461,663715,806744,091517,851
Average number of employees55332

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: KARMA ONCOLOGY LIMITED

Company

KARMA ONCOLOGY LIMITED is a private limited company registered with Companies House under company number SC422204. It was incorporated on 18 Apr 2012. Its status is active. The registered office is in Glasgow (G74). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £517,851, down 30.4% on the previous year. Cash at bank and in hand was £476,365. Total assets were £517,617 and total liabilities £5,107. The company had an average of 2 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 25 Jan 2027.